Literature DB >> 16009322

DAP-kinase--protector or enemy in apoptotic cell death.

Regine Schneider-Stock1, Albert Roessner, Oliver Ullrich.   

Abstract

Death-associated protein (DAP)-kinase, a member of a novel subfamily of pro-apoptotic serine/threonine kinases, was recently identified as a new tumor suppressor gene with multiple functions in programmed cell death. This 160-kDa protein consists of different interaction domains that enable it to participate in seemingly contradictory pathways such as elimination of premalignant cells or cytoprotection in cellular homoeostasis. DAP-kinase is frequently inactivated by aberrant promoter methylation in many cancer types, and its expression was shown to be a useful molecular marker for cancer prognosis. Moreover, DAP-kinase is considered a regulator of neuronal apoptosis. Future investigations should allow for the evaluation of DAP-kinase as a potential target for both pro- and anti-apoptotic therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16009322     DOI: 10.1016/j.biocel.2005.02.019

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  6 in total

1.  Early involvement of death-associated protein kinase promoter hypermethylation in the carcinogenesis of Barrett's esophageal adenocarcinoma and its association with clinical progression.

Authors:  Doerthe Kuester; Altaf A Dar; Christopher C Moskaluk; Sabine Krueger; Frank Meyer; Roland Hartig; Manfred Stolte; Peter Malfertheiner; Hans Lippert; Albert Roessner; Wael El-Rifai; Regine Schneider-Stock
Journal:  Neoplasia       Date:  2007-03       Impact factor: 5.715

2.  Quantitative detection of promoter hypermethylation as a biomarker of acute kidney injury during transplantation.

Authors:  T K Mehta; M O Hoque; R Ugarte; M H Rahman; E Kraus; R Montgomery; K Melancon; D Sidransky; H Rabb
Journal:  Transplant Proc       Date:  2006-12       Impact factor: 1.066

3.  Regulation of death-associated protein kinase. Stabilization by HSP90 heterocomplexes.

Authors:  Liguo Zhang; Kenneth P Nephew; Patricia J Gallagher
Journal:  J Biol Chem       Date:  2007-02-26       Impact factor: 5.157

4.  The role of epigenetic alterations in papillary thyroid carcinogenesis.

Authors:  Ogechukwu P Eze; Lee F Starker; Tobias Carling
Journal:  J Thyroid Res       Date:  2011-06-14

5.  Meta-analysis of promoter methylation in eight tumor-suppressor genes and its association with the risk of thyroid cancer.

Authors:  Fatemeh Khatami; Bagher Larijani; Ramin Heshmat; Abbasali Keshtkar; Mahsa Mohammadamoli; Ladan Teimoori-Toolabi; Shirzad Nasiri; Seyed Mohammad Tavangar
Journal:  PLoS One       Date:  2017-09-19       Impact factor: 3.240

6.  Epigenetic regulation of RUNX3 in thyroid carcinoma.

Authors:  Kyong Hye Joung; Minho Shong
Journal:  Korean J Intern Med       Date:  2012-11-27       Impact factor: 2.884

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.